JCS Pharmaceuticals
JCS Pharmaceutiques, Inc.
JCS Pharmaceuticals, Inc. a été créée pour commercialiser des produits pharmaceutiques, des nutraceutiques, des compléments alimentaires, des dispositifs médicaux et d'autres produits similaires. Le premier produit introduit par JCSPI aux Philippines était Genacol®, un complément alimentaire canadien contenant du collagène AminoLock® pour les douleurs articulaires et musculaires.
- Type
- distributor seeking brands
- Location
- Netherlands
- Website
- https://jcspharmaceuticals.com
- Categories
- Production pharmaceutique, Fournitures médicales et de santé, Compléments et bien-être
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)